| 10x Genomics, Inc.. (1/7/19). "Press Release: 10x Genomics Lands New Financing". Pleasanton, CA. |
2019-01-07 |
| 10x Genomics, Inc.. (10/5/20). "Press Release: 10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions". Pleasanton, CA. |
2020-10-05 |
| 10x Genomics, Inc.. (2/24/21). "Press Release: 10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event. Acquires Tetramer Shop, Reveals Details on Upcoming Products". Pleasanton, CA. |
2021-02-24 |
| 2cureX AB. (1/28/21). "Press Release: 2cureX Appoints Kenneth Graabek Johansen, an Experienced Business and Financial Executive, as New CFO". Copenhagen. |
2021-01-28 |
| 2cureX AB. (12/16/24). "Press Release: 2cureX AB Announces the Appointment of Dan Honeywell as CEO, Ushering in a New Era of Commercial Expansion of Breakthrough Precision Oncology Products". |
2024-12-16 |
| 4SC AG. (10/7/19). "Press Release: 4SC AG Resolves to Issue New Shares, Santo and ATS Undertake to Subscribe / Buy the New Shares [Not for US, AU, CA, et al.]". Planegg-Martinsried. |
2019-10-07 |
| AAX Biotech AB. (11/28/23). "Press Release: AAX Biotech Forms Strategic Collaboration with Oblique Therapeutics for Therapeutic Antibody Development". |
2023-11-28 |
| AAX Biotech AB. (9/28/23). "Press Release: AAX Biotech Welcomes New CEO to Drive Advancements in Next-generation Antibody Therapeutics". |
2023-09-28 |
| AB Sciex (d/b/a Sciex). (11/1/21). "Press Release: Sciex and Evosep Will Collaborate to Provide Robust, High-throughput Proteomics Workflows". |
2021-11-01 |
| Abera Bioscience AB. (3/29/22). "Press Release: Abera Bioscience Signs Agreement with NorthX Biologics for GMP Manufacturing". |
2022-03-29 |
| Abivax S.A.. (3/11/19). "Press Release: Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn’s and Colitis Organisation (ECCO)". Paris. |
2019-03-11 |
| Aboleris Pharma. (9/18/23). "Press Release: Aboleris Pharma Announces €27 Million in Series A Financing to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases". Gosselies. |
2023-09-18 |
| Acadia Pharmaceuticals Inc.. (11/26/24). "Press Release: Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711". San Diego, CA. |
2024-11-26 |
| Accession Therapeutics Ltd.. (11/21/22). "Press Release: Accession Therapeutics Raises £16.6m to Advance Potent Immunotherapies towards Clinical Trials". Oxford. |
2022-11-21 |
| Accession Therapeutics Ltd.. (7/19/23). "Press Release: Chief Business Officer Appointed at Accession Therapeutics as Company Prepares for Clinical Trials". Oxford. |
2023-07-19 |
| Accession Therapeutics Ltd.. (9/20/21). "Press Release: Bent Jakobsen Starts Novel Immune-oncology Firm Accession Therapeutics, Primavera Venture Partners and Birk Venture among First Investors". Oxford. |
2021-09-20 |
| Acesion Pharma ApS. (9/26/23). "Press Release: Acesion Pharma Closes Oversubscribed €45M Series B Financing Round". Copenhagen. |
2023-09-26 |
| Actimed Therapeutics Ltd.. (6/10/21). "Press Release: Actimed Therapeutics Announces Successful Closing of £2.5m Extended Seed B Funding Round". London. |
2021-06-10 |
| Active Biotech AB. (8/4/22). "Press Release: Active Biotech Announces a Rights Issue of approximately SEK 55 Million [Not for release in US, AU, CA, JP, et al.]". |
2022-08-04 |
| ADC Therapeutics S.A.. (12/21/22). "Press Release: ADC Therapeutics and Sobi Announce European Commission Approval of Zynlonta (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma". Lausanne. |
2022-12-21 |
| ADC Therapeutics S.A.. (7/8/22). "Press Release: ADC Therapeutics Announces Exclusive License Agreement with Sobi to Develop and Commercialize Zynlonta (loncastuximab tesirine-lpyl) in Europe and Select International Territories". Lausanne. |
2022-07-08 |
| Adcendo ApS. (1/5/23). "Press Release: Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform". Copenhagen. |
2023-01-05 |
| Adcendo ApS. (11/25/24). "Press Release: Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline". Copenhagen. |
2024-11-25 |
| Adcendo ApS. (12/19/22). "Press Release: GlyTherix and Adcendo Announce Agreement for Development of Antibody Drug Conjugate". |
2022-12-19 |
| Adcendo ApS. (4/29/21). "Press Release: Adcendo Raises EUR 51 Million in Series A Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Cancers". Copenhagen. |
2021-04-29 |
| Adcendo ApS. (4/4/23). "Press Release: Adcendo ApS Announces Extension of Series A Financing to 82M EUR to Ensure Broad Development of its First-in-class ADC Pipeline". Copenhagen. |
2023-04-04 |
| Adcendo ApS. (5/29/24). "Press Release: Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline". Copenhagen. |
2024-05-29 |
| Adcendo ApS. (5/30/23). "Press Release: Adcendo ApS Announces Option License Agreement with Duality Biologics to Enhance Optionality to Further Expand First-in-class ADC Pipeline". Copenhagen. |
2023-05-30 |
| Adcendo ApS. (7/6/21). "Press Release: Adcendo Appoints Michael Pehl as Chief Executive Officer". |
2021-07-06 |
| Adcendo ApS. (8/20/24). "Press Release: Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor". Copenhagen & Shanghai. |
2024-08-20 |
| Adelis Equity Partners. (8/22/22). "Press Release: Adelis Equity Partners Raises Fund Continuation Vehicle for SSI Diagnostica Group, Enabling Transformational Acquisition". |
2022-08-22 |
| Adragos Pharma GmbH. (11/25/24). "Press Release: Adragos Pharma Acquires Baccinex – a Leading Swiss Sterile Fill-Finish Expert". Munich & Courroux. |
2024-11-25 |
| Advicenne S.A.. (1/7/21). "Press Release: Advicenne Announces the Appointment of Peter Meeus as Chief Executive Officer". Paris. |
2021-01-07 |
| Affibody Medical AB. (12/23/22). "Press Release: Affibody Signs €20 Million Loan Agreement with the EIB to Finance the Development of Next Generation’s Biopharmaceuticals against Cancer and Inflammatory Diseases". Solna. |
2022-12-23 |
| Affimed N.V.. (3/31/22). "Press Release: Affimed Reports 2021 Financial Results and Highlights Recent Operational Progress". Heidelberg. |
2022-03-31 |
| Affimed N.V.. (6/16/21). "Press Release: Affimed Announces Appointment of Uta Kemmerich-Keil to its Supervisory Board". Heidelberg. |
2021-06-16 |
| AGC Biologics. (8/20/21). "Press Release: AGC Biologics Announces the Groundbreaking of its New Facility at its Copenhagen, Denmark Site". Copenhagen. |
2021-08-20 |
| Agilent Technologies Inc.. (1/6/23). "Press Release: Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications". Santa Clara, CA & Marlborough, MA. |
2023-01-06 |
| Agilent Technologies Inc.. (3/2/20). "Press Release: Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions". Santa Clara, CA & Copenhagen. |
2020-03-02 |
| Agilent Technologies Inc.. (6/11/19). "Press Release: Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC)". Santa Clara, CA. |
2019-06-11 |
| Agomab Therapeutics N.V.. (10/10/23). "Press Release: Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline". Ghent. |
2023-10-10 |
| AH Diagnostics A/S. (4/3/23). "Press Release: Helle Zacho Becomes the New CEO of the AH Diagnostics Group". |
2023-04-03 |
| AH Diagnostics A/S. (9/1/22). "Press Release: AH Diagnostics AS Acquires DiuVita Diagnostics AS". |
2022-09-01 |
| AI Medical Technology. (1/24/23). "Press Release: AI Medical Technology Nets SEK10.8 Million to Accelerate Dermalyser AI-driven Diagnostic Support Tool for Skin Cancer". Stockholm. |
2023-01-24 |
| Aion Labs. (1/30/24). "Press Release: Aion Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery". Rehovot. |
2024-01-30 |
| Albumedix Ltd.. (5/26/20). "Press Release: Albumedix Announces Jonas Skjødt Møller as New Chief Executive Officer". |
2020-05-26 |
| Albumedix Ltd.. (6/1/20). "Press Release: Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer". |
2020-06-01 |
| Alentis Therapeutics AG. (11/12/24). "Press Release: Alentis Therapeutics Raises $181.4 Million in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors". Basel. |
2024-11-12 |
| Alentis Therapeutics AG. (4/13/23). "Press Release: Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1". Basel. |
2023-04-13 |
| Alentis Therapeutics AG. (9/3/24). "Press Release: Alentis Appoints Jonathan Freve CFO". Basel. |
2024-09-03 |
| Alligator Bioscience AB. (1/7/19). "Press Release: Alligator Bioscience Launches RUBY, a Novel Concept in Bispecific Antibody Formats". Lund. |
2019-01-07 |
| Alligator Bioscience AB. (11/29/19). "Press Release: Alligator Bioscience AB Appoints Chief Operating Officer". Lund. |
2019-11-29 |
| Alligator Bioscience AB. (12/11/19). "Press Release: CFO Per-Olof Schrewelius Leaves Alligator Bioscience". Lund. |
2019-12-11 |
| Alligator Bioscience AB. (12/17/19). "Press Release: First Patient Dosed with ATOR-1017 Developed for Metastasized Cancer". Lund. |
2019-12-17 |
| Alligator Bioscience AB. (2/12/20). "Press Release: Alligator Bioscience AB Year-end Report January-December 2019". |
2020-02-12 |
| Alligator Bioscience AB. (3/18/21). "Press Release: Alligator Bioscience Appoints Søren Bregenholt as New CEO". Lund. |
2021-03-18 |
| Alligator Bioscience AB. (3/22/23). "Press Release: Alligator Intends to Carry Out a 91 Percent Secured Rights Issue of Units of Approximately SEK 199 Million [Not for US, AU, et al.]". |
2023-03-22 |
| Alligator Bioscience AB. (3/5/20). "Press Release: Alligator Bioscience Appoints Andreas Johannesson as Interim Chief Financial Officer". Lund. |
2020-03-05 |
| Alligator Bioscience AB. (4/15/21). "Press Release: Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy". Lund. |
2021-04-15 |
| Alligator Bioscience AB. (7/31/19). "Press Release: Alligator Bioscience Regains Global Rights from Janssen to CD40 Agonistic Antibody, ADC-1013 (JNJ-64457107)". Lund. |
2019-07-31 |
| Alligator Bioscience AB. (8/20/19). "Press Release: Alligator Bioscience Signs Antibody Agreement for Greater China with Biotheus Inc.". Lund. |
2019-08-20 |
| Almirall S.A.. (2/17/21). "Press Release: Almirall and MC2 Therapeutics Enter a License, Collaboration and Commercialization Agreement for European Rights to Wynzora Cream for Treatment of Plaque Psoriasis". Barcelona & Copenhagen. |
2021-02-17 |
| Alzinova AB. (1/24/23). "Press Release: Alzinova Recruits Business Development Director". |
2023-01-24 |
| Amarna Therapeutics B.V.. (10/16/19). "Press Release: Amarna Therapeutics Raises €10 Million to Progress Lead Development Candidate into Clinical Trials and Appoints a New Supervisory Board". Leiden. |
2019-10-16 |
| Amarna Therapeutics B.V.. (12/1/21). "Press Release: Amarna Therapeutics Secures Additional €5 ($5.7) Million to Advance Its Transformative Gene Therapy Platform towards Clinical Trials". Leiden. |
2021-12-01 |
| Amarna Therapeutics B.V.. (9/3/20). "Press Release: Dutch Amarna Therapeutics Announces the Appointment of Steen Klysner as Chief Executive Officer". Leiden. |
2020-09-03 |
| Amniotics AB. (1/20/22). "Press Release: Amniotics Secures Funding of SEK 4,8 Million from Vinnova to Develop Stem Cell Therapies". |
2022-01-20 |
| Amolyt Pharma SAS. (1/6/23). "Press Release: Amolyt Pharma Announces $138 Million Series C Financing led by Sofinnova Partners and co-led by Intermediate Capital Group". Lyon & Cambridge, MA. |
2023-01-06 |
| Amolyt Pharma SAS. (3/14/24). "Press Release: Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca. AstraZeneca Will Acquire Amolyt Pharma for up to $1.05 Billion in Total Consideration". Lyon & Cambridge, MA. |
2024-03-14 |
| Amolyt Pharma SAS. (9/16/21). "Press Release: Amolyt Pharma Announces $80 Million Series B Financing led by Sectoral Asset Management and Andera Partners". Lyon & Cambridge, MA. |
2021-09-16 |
| AMR Action Fund. (2/7/22). "Press Release: AMR Action Fund Opens European Office". Boston, MA. |
2022-02-07 |
| Amra Medical AB. (2/5/19). "Press Release: Amra Medical Appoints Allison Robbins as Chief Financial Officer". Linköping. |
2019-02-05 |
| Amra Medical AB. (9/10/19). "Press Release: Amra Announces Strategic Partnership with Japanese Leading Imaging CRO, Micron, Inc., to Support Clinical Trials in Japan". Linköping. |
2019-09-10 |
| Amra Medical AB. (9/17/19). "Press Release: Amra Medical Welcomes Jonas Lindqvist to the Team as Director of Operations as It Strengthens Its Delivery Capabilities in Clinical Trials". Linköping. |
2019-09-17 |
| AMSilk GmbH. (4/4/23). "Press Release: AMSilk Announces Extension of Series C Financing to EUR 54M". Munich. |
2023-04-04 |
| AMSilk GmbH. (5/11/21). "Press Release: AMSilk Raises EUR 29 M to Accelerate Commercialization of Its High-performance Bio-based Silk Polymers". Munich. |
2021-05-11 |
| Andera Partners. (10/10/22). "Press Release: Andera Partners Raises Its Largest Life Sciences Fund at €456M, Demonstrating the Attractiveness of Its Activity and of the Sector". Paris. |
2022-10-10 |
| Angelini Ventures S.p.A.. (3/21/24). "Press Release: Angelini Ventures Invests into Extended €75.8 Million ($82 Mmillion) Series C Financing Round for Nouscom". Rome. |
2024-03-21 |
| Anocca AB. (7/22/21). "Press Release: Anocca Raises $47m in a Series B Financing to Advance Its Industrialised Approach to TCR-T Cellular Immunotherapy". Södertälje. |
2021-07-22 |
| Antag Therapeutics. (12/4/24). "Press Release: Antag Therapeutics Announces €80 Million Series A Financing". Copenhagen. |
2024-12-04 |
| Apeiron Biologics AG. (4/2/20). "Press Release: Apeiron Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19". Vienna. |
2020-04-02 |
| APK AG. (2/8/23). "Press Release: LyondellBasell and KIRKBI Invest in APK to Develop Recycling technology". Rotterdam, Billund & Merseburg. |
2023-02-08 |
| Aprea Therapeutics, Inc.. (12/28/20). "Press Release: Aprea Therapeutics Announces Results of Primary Endpoint from Phase 3 Trial of Eprenetapopt in TP53 Mutant Myelodysplastic Syndromes (MDS)". Boston, MA. |
2020-12-28 |
| Aptamer Group Ltd.. (8/25/21). "Press Release: Aptamer Group and Bio-Works Technologies Partner to Enable Improved Solutions for Gene Therapy Manufacturing". York & Uppsala. |
2021-08-25 |
| Aqilion AB. (12/3/21). "Press Release: Aqilion Strengthens the Company’s Pipeline through the Acquisition of a Phase-1 Ready Anti-inflammatory Program from LEO Pharma". |
2021-12-03 |
| Aqilion AB. (5/11/20). "Press Release: Torgeir Vaage Joins Aqilion as Chief Financial Officer". Helsingborg. |
2020-05-11 |
| Arctic Therapeutics. (1/22/25). "Press Release: Arctic Therapeutics Announces €26.5M Oversubscribed Series A Financing". Reykjavik & Philadelphia, PA. |
2025-01-22 |
| Ardena Holding N.V.. (5/18/21). "Press Release: Investment in Flow Cytometry Unlocks the Secrets of Single Cells". Gent. |
2021-05-18 |
| Ardena Holding N.V.. (6/3/24). "Press Release: Ardena Appoints Jeremie Trochu as Chief Executive Officer". Ghent. |
2024-06-03 |
| Argenx SE. (4/17/23). "Press Release: Argenx and Genmab Enter Partnership to Advance Antibody Therapies in Immunology and Oncology". Amsterdam. |
2023-04-17 |
| Argobio SAS. (1/7/25). "Press Release: Next-generation RNA Company Inverna Therapeutics Launched by Argobio and University of Southern Denmark". Odense. |
2025-01-07 |
| Argobio SAS. (12/16/21). "Press Release: Argobio and GeneCode Partner on Parkinson’s Disease in Argobio’s First Announced Research Agreement". Paris & Tallinn. |
2021-12-16 |
| ArgusEye AB. (5/13/24). "Press Release: ArgusEye Closes €2.8 Million Funding to Accelerate Bioprocessing". Stockholm. |
2024-05-13 |
| Ariceum Therapeutics GmbH. (6/8/22). "Press Release: Ariceum Therapeutics Launches with EUR 25M Series A to Advance Lead Asset, Satoreotide, for the Treatment of Low- and High-Grade Neuroendocrine Cancers". Berlin. |
2022-06-08 |
| Arix Bioscience plc. (9/30/19). "Press Release: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics". London. |
2019-09-30 |
| Artax Biopharma, Inc.. (5/11/22). "Press Release: Artax Biopharma Closes Financing to Advance Clinical Stage First-in-Class Oral Immunomodulator to Treat T Cell-Mediated Diseases". Cambridge, MA. |
2022-05-11 |
| Asahi Kasei Corporation. (11/25/19). "Press Release: Asahi Kasei to Acquire Veloxis Pharmaceuticals Inc. to Accelerate Transformation into a Global Health Care Company". Tokyo. |
2019-11-25 |
| Asahi Kasei Corporation. (11/25/19). "Press Release: Presentation – Accelerating Transformation into a Global Health Care Company. Acquisition of U.S.-based Veloxis Pharmaceuticals Inc.". Tokyo. |
2019-11-25 |
| Asahi Kasei Corporation. (5/28/24). "Press Release: Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company". |
2024-05-28 |
| Ascendis Pharma A/S. (3/4/18). "Press Release: Ascendis Pharma A/S Announces Proposed Public Offering of ADSs". Copenhagen. |
2019-03-04 |
![[LSS] Life-Sciences-Scandinavia.com - The Scandinavian Life Sciences Web Portal](/images/basics/lss-life-sciences-scandinavia-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
